A new in vitro dormancy model of <i>Mycobacterium tuberculosis</i>

A new in vitro dormancy model of <i>Mycobacterium tuberculosis</i>

The article describes a new in vitro dormancy model of M. tuberculosis based on cultivation with deprivation of four components of the standard medium of Mediumbrook 7H9. The modeling method and characteristics of the obtained dormant phenotype of M. tuberculosis are described in detail, and fields...

Full description

Bibliographic Details
Main Authors:	Ya. R. Bаtyrshinа, Ya. Sh. Shvarts
Format:	Article
Language:	Russian
Published:	New Terra Publishing House 2020-04-01
Series:	Туберкулез и болезни лёгких
Subjects:	mycobacterium tuberculosis дормантность микобактерий туберкулеза модели дормантности m. tuberculosis in vitro старвация депривация компонентов питательных сред
Online Access:	https://www.tibl-journal.com/jour/article/view/1404

Similar Items

DETECTION OF TISSUE MYCOBACTERIUM TUBERCULOSIS BY DIFFERENTIATING IMMUNOPEROXIDASE STAINING
by: A. P. Lysenko, et al.
Published: (2014-10-01)

CLINICAL AND EPIDEMIOLOGICAL VALUE OF VARIOUS GENOTYPES OF M. TUBERCULOSIS AND CHANGES IN THEIR TRANSMISSION IN SARATOV REGION DURING 4-YEAR PERIOD
by: T. Yu. Sаlinа, et al.
Published: (2018-05-01)

UNDERSTANDING OF MYCOBACTERIUM TUBERCULOSIS EVOLUTION
by: V. L. Dobin
Published: (2018-09-01)

EXPRESSION OF THE ICL AND HSPX GENES INDUCED DURING SURVIVAL IN THE HOST IN MYCOBACTERIUM TUBERCULOSIS W CLUSTER STRAINS
by: S. N. Andreevskaya, et al.
Published: (2014-01-01)

PREVALENCE AND SPECIFIC REGIONAL FEATURES OF GENETIC STRUCTURE AND DRUG RESISTANCE OF TUBERCULOSIS MYCOBACTERIA OF HAARLEM FAMILY AMONG TUBERCULOSIS PATIENTS IN SARATOV REGION
by: T. Yu. Sаlinа, et al.
Published: (2017-05-01)

EFFECTIVENESS OF COMBINATION OF ISONIAZID AND SILVER NANOPARTICLES IN THE TREATMENT OF EXPERIMENTAL TUBERCULOSIS
by: A. V. Zаkhаrov, et al.
Published: (2017-06-01)

A CLINICAL CASE OF EFFECTIVE TREATMENT OF EXTENSIVE DRUG RESISTANCE TUBERCULOSIS WITH NEW ANTI-TUBERCULOSIS DRUGS
by: M. V. Pаvlovа, et al.
Published: (2018-01-01)

The prevalence, clinical and epidemiological significance of rare genotypes of M. tuberculosis isolated from tuberculosis patients in Saratov Region
by: T. Yu. Salina, et al.
Published: (2020-03-01)

Characterization of drug susceptibility of Mycobacterium tuberculosis isolated from new cases of tuberculosis concurrent with HIV infection
by: G. V. Panov, et al.
Published: (2015-02-01)

ВЛИЯНИЕ ГЛУТОКСИМА НА АНТИМИКОБАКТЕРИАЛЬНУЮ АКТИВНОСТЬ ИЗОНИАЗИДА В ОТНОШЕНИИ ЛЕКАРСТВЕННО-УСТОЙЧИВЫХ ШТАММОВ MYCOBACTERIUM TUBERCULOSIS
Published: (2014-09-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

CLINICAL CASES OF FOCAL PULMONARY TUBERCULOSIS IN CHILDREN WITH MINIMUM INVOLVEMENT IN MULTIDRUG RESISTANCE IN MYCOBACTERIUM TUBERCULOSIS
by: M. F. Gubkina, et al.
Published: (2015-03-01)

Miru-vntr technique for molecular epidemiological studies of tuberculosis
by: E. V. Аntusheva, et al.
Published: (2016-04-01)

About the standardization and quality of laboratory tests aimed at diagnostics and monitoring of tuberculosis chemotherapy
by: D. V. Vаkhrushevа, et al.
Published: (2018-10-01)

THE CASE OF MENINGOENCEPHALITIS IN A CHILD FROM THE SOURCE TUBERCULOSIS INFECTION
by: L. A. Gusnisheva, et al.
Published: (2015-09-01)

EXPERIENCE OF TREATMENT OF MULTIPLE DRUG RESISTANT TUBERCULOSIS PATIENTS WITH BEDAQUILINE IN AMUR REGION
by: L. Yu. Tikhonova, et al.
Published: (2018-07-01)

Metabolic Versatility of <i>Mycobacterium tuberculosis</i> during Infection and Dormancy
by: Dorothy Pei Shan Chang, et al.
Published: (2021-02-01)

Burden of tuberculosis and TB/HIV co-infection in Dushanbe
by: B. P. Pirmakhmadzoda, et al.
Published: (2021-03-01)

Mycobacteriophage-based test system for phenotypic drug sensitivity of clinical isolates of tuberculous mycobacteria
by: M. B. Lapenkova, et al.
Published: (2020-09-01)

Drug resistance of <i>M. tuberculosis</i> (historical aspects, current level of knowledge)
by: I. A. Burmistrova, et al.
Published: (2020-02-01)

Represented results tuberculosis lung patients with firsting MDR in Republic of Buryatia
by: S. V. Nikolayeva, et al.
Published: (2012-08-01)

Treatment outcomes in new pulmonary tuberculosis cases depending on the main genotypes of <i>Mycobacterium tuberculosis</i> in the Republic of Sakha (Yakutia)
by: N. E. Evdokimov, et al.
Published: (2021-02-01)

EPIDEMIC SITUATION AND TREATMENT PROSPECTS OF MULTIPLE RESISTANT TUBERCULOSIS IN KANTY-MANSIYSKY AUTONOMOUS REGION
by: E. S. Ershovа, et al.
Published: (2018-05-01)

STUDY OF NOSOCOMIAL INFECTION BY IS6110 RFLP AND MIRU-VNTR METHODS IN THE UNIT FOR PATIENTS WITH MULTIDRUG-RESISTANT TUBERCULOSIS
by: N. A. Vlasova, et al.
Published: (2014-01-01)

EFFICIENCY OF PULMONARY TUBERCULOSIS CHEMOTHERAPY IN NEW CASES DEPENDING ON THE TIME OFDRUG RESISTANCE DETECTION
by: M. V. Burаkovа, et al.
Published: (2017-12-01)

INVESTIGATION OF RANGES AND FREQUENCY OF MUTATIONS IN THE embB GENE IN MYCOBACTERIUMTUBERCULOSIS ASSOCIATED WITH RESISTANCE TO ETHAMBUTOL USING REAL-TIME POLYMERASE CHAINREACTION
by: Yu. S. Аlyapkinа, et al.
Published: (2017-12-01)

Metabolic versatility of Mycobacterium tuberculosis during infection and dormancy
by: Chang, Dorothy Pei Shan, et al.
Published: (2021)

ДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКОГО МЕТОДА GENEXPERT MTB/RIF ДЛЯ ДИАГНОСТИКИ ТУБЕРКУЛЕЗА В СРАВНЕНИИ С ТРАДИЦИОННЫМИ МЕТОДАМИ
by: Е. А. Лаптева, et al.
Published: (2023-05-01)

Diagnosis and clinical and X-ray characteristics of pulmonary tuberculosis in adolescents
by: M. V. Pavlova, et al.
Published: (2015-01-01)

Delamanid is a new anti-tuberculosis drug: use, limitations, and prospects
by: V. N. Zimina, et al.
Published: (2021-03-01)

THE SAFETY AND EFFICACY OF RIFAPENTINE USED TO TREAT DRUG-SUSCEPTIBLE PULMONARY TUBERCULOSIS
by: N. V. Litvinova, et al.
Published: (2014-04-01)

In vitro activities of contezolid (MRX-I) against drug-sensitive and drug-resistant Mycobacterium tuberculosis
by: Huiru An, et al.
Published: (2023-10-01)

Gene mutation and drug resistance of <i>M. tuberculosis</i> in the patients followed up in the city of Moscow
by: M. A. Krasnova, et al.
Published: (2020-01-01)

Tuberculosis patients co-infected with Mycobacterium bovis and Mycobacterium tuberculosis in an urban area of Brazil
by: Marcio Roberto Silva, et al.
Published: (2013-05-01)

Tuberculosis patients co-infected with Mycobacterium bovis and Mycobacterium tuberculosis in an urban area of Brazil
by: Marcio Roberto Silva, et al.
Published: (2013-05-01)

Genetic factors affecting storage and utilization of lipids during dormancy in Mycobacterium tuberculosis
by: Alexander Sturm, et al.
Published: (2024-02-01)

Applications of Transcriptomics and Proteomics for Understanding Dormancy and Resuscitation in Mycobacterium tuberculosis
by: Manikuntala Kundu, et al.
Published: (2021-03-01)

IMPACT OF BEDAQUILINE ON THE EFFICIENCY OF COMPREHENSIVE THERAPY OF RESPIRATORY TUBERCULOSIS
by: M. N. Kondakova, et al.
Published: (2018-07-01)

The Interplay between <i>Mycobacterium tuberculosis</i> and Human Microbiome
by: Michelle Nguyen, et al.
Published: (2024-01-01)

<i>Mycobacterium tuberculosis</i> Dormancy: How to Fight a Hidden Danger
by: Elena G. Salina, et al.
Published: (2022-11-01)